Author | Vassiliki A. Papadimitrakopoulou, MD


The Future of NSCLC: Molecular Profiles Guiding Treatment Decisions

June 14, 2011

ByAnne S. Tsao, MD|Vassiliki A. Papadimitrakopoulou, MD

The authors of "ALK-Targeted Therapy for Lung Cancer: Ready for Prime Time," in this issue of ONCOLOGY, address the newest developments in the field of targeted therapies for advanced non–small-cell lung cancer (NSCLC).